Breaking News Instant updates and real-time market news.

2022-07-01 12:42:41 HPGLY Hapag-Lloyd $129.70 / -0.89 (-0.68%) 12:42 07/01/22 07/01 12:42 07/01/22 12:42	Hapag-Lloyd price target raised to EUR 173 from EUR 171 at JPMorgan JPMorgan analyst Samuel Bland raised the firm's price target on Hapag-Lloyd to EUR 173 from EUR 171 and keeps an Underweight rating on the shares.

2022-07-01 12:42:41

HPGLY

Hapag-Lloyd

$129.70 / -0.89 (-0.68%)

12:42

07/01/22

07/01

12:42

07/01/22

12:42

Hapag-Lloyd price target raised to EUR 173 from EUR 171 at JPMorgan

JPMorgan analyst Samuel Bland raised the firm's price target on Hapag-Lloyd to EUR 173 from EUR 171 and keeps an Underweight rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Biofrontera Inc. expects cash to fund operations for at least next 12 months » 08:37 08/12/22 08/12 08:37 08/12/22 08:37 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) As of June 30, 2022,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08:35 Today Biofrontera Inc. expects 2022 revenue up at least 30% vs. 2021 08:35 Today Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	BTCS reports Q2 EPS (61c) vs (89c) last year » 08:36 08/12/22 08/12 08:36 08/12/22 08:36 BTCS BTCS $1.75 / -0.09 (-4.89%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BTCS BTCS $1.75 / -0.09 (-4.89%) 07/05/22 BTCS appoints Adele Carey as VP, investor relations 05/17/22 BTCS to join panel discussing cryptocurrency hosted by FORCE Family Office 05/11/22 BTCS adds Axie Infinity to blockchain infrastructure operations 04/27/22 BTCS adds Kava to its blockchain infrastructure operations BTCS BTCS $1.75 / -0.09 (-4.89%) 03/28/22 H.C. Wainwright BTCS initiated with a Buy at H.C. Wainwright BTCS BTCS $1.75 / -0.09 (-4.89%) 05/16/22 BTCS reports Q1 EPS (47c) vs ($2.43) last year 03/14/22 BTCS reports 2021 EPS ($3.09) vs. (86c) last year
Earnings	Biofrontera Inc. expects 2022 revenue up at least 30% vs. 2021 » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Biofrontera Inc. affirms… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08:35 Today Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	PhaseBio reports Q2 EPS (34c) vs. (60c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PHAS PhaseBio $1.19 / +0.05 (+4.39%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio announces successful Pre-BLA meeting with U.S. FDA for bentracimab 04/04/22 PhaseBio: primary reversal endpoint in achieved bentracimab Phase 2b trial 03/08/22 PhaseBio completes bentracimab PPQ campaign PHAS PhaseBio $1.19 / +0.05 (+4.39%) 10/13/21 Stifel PhaseBio resumed with a Buy at Stifel PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 PhaseBio reports Q1 EPS (23c), consensus (66c) 03/24/22 PhaseBio reports Q4 EPS (90c), consensus (59c) PHAS PhaseBio $1.19 / +0.05 (+4.39%) 05/16/22 Fly Intel: Pre-market Movers
Earnings	Biofrontera Inc. reports Q2 EPS (5c) vs. (46c) last year » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) Reports Q2 revenue $4.5M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 08/01/22 Biofrontera announces patent in Australia for novel illumination protocols 07/27/22 Biofrontera Inc. announces exercise of existing warrants 07/12/22 Biofrontera Inc. sees Q2 product revenue $4.4M-$4.6M 05/16/22 Biofrontera Inc. announces pricing of $9.4M private placement BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 12/30/21 Benchmark Biofrontera AG financial reporting may now change, says Benchmark 12/15/21 Benchmark Biofrontera initiated with a Buy at Benchmark 11/24/21 Roth Capital Roth Capital bullish on Biofrontera, initiates with a Buy 11/24/21 Roth Capital Biofrontera initiated with a Buy at Roth Capital BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/13/22 Biofrontera Inc. reaffirms FY22 revenue view up at least 30% vs 2021 05/13/22 Biofrontera Inc. reports Q1 EPS 32c vs (44c) last year 04/08/22 Biofrontera Inc. sees 2022 revenue up 30% vs. 2021 04/08/22 Biofrontera Inc. reports Q4 EPS ($1.29) vs. ($2.12) last year 29 Oct BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 04/08/22 Fly Intel: Pre-market Movers 11:00 Today Biofrontera Inc. - BFRI BFRI Biofrontera Inc. $1.38 / -0.03 (-2.13%) 05/11/22 Eighteen new option listings on May 11th
Earnings	Point Biopharma reports Q2 EPS (27c), consensus (22c) » 08:35 08/12/22 08/12 08:35 08/12/22 08:35 PNT Point Biopharma $8.09 / -0.91 (-10.11%) "We continue to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PNT Point Biopharma $8.09 / -0.91 (-10.11%) 08/08/22 Point Biopharma to host investor education event on August 18 06/21/22 Point Biopharma appoints Horvath as EVP, Commercial 05/16/22 Point Biopharma unveils FRONTIER: pan-cancer clinical program 05/13/22 Point Biopharma sees cash, equivalents funding operations into 1Q24 PNT Point Biopharma $8.09 / -0.91 (-10.11%) 07/06/22 William Blair William Blair starts Point Biopharma at Outperform on 'superior' manufacturing 07/06/22 William Blair Point Biopharma initiated with an Outperform at William Blair 05/26/22 Jefferies Point Biopharma assumed with Buy from Hold at Jefferies 05/13/22 Piper Sandler Point Biopharma price target lowered to $14 from $17 at Piper Sandler PNT Point Biopharma $8.09 / -0.91 (-10.11%) 05/13/22 Point Biopharma reports Q1 EPS (18c), consensus (21c) 03/25/22 Point Biopharma reports Q4 EPS (16c), consensus (23c)
General news	July export prices down 3.3% vs. last month, consensus 0.1% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July export prices up 13.1% vs. last year 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	July import prices up 8.8% vs. last year, consensus 9.4% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Downgrade	Mister Car Wash downgraded to Equal Weight from Overweight at Morgan Stanley » 08:34 08/12/22 08/12 08:34 08/12/22 08:34 MCW Mister Car Wash $12.00 / -0.25 (-2.04%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/03/22 Mister Car Wash acquires Top Wash in Minnesota 06/27/22 Mister Car Wash falls -5.3% 04/29/22 Mister Car Wash acquires Speedwash, terms undisclosed 03/24/22 Mister Car Wash jumps over 3% to $16.39 after Q4 earnings beat MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 06/27/22 Goldman Sachs Mister Car Wash downgraded to Sell from Neutral at Goldman Sachs 05/13/22 BMO Capital Mister Car Wash price target lowered to $18 from $23 at BMO Capital 05/13/22 Piper Sandler Mister Car Wash price target lowered to $13 from $18 at Piper Sandler 03/25/22 BMO Capital Mister Car Wash price target lowered to $23 from $25 at BMO Capital MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Mister Car Wash cuts FY22 EPS view to 36c-39c from 44c-47c, consensus 45c 08/11/22 Mister Car Wash reports Q2 adjusted EPS 11c, consensus 12c 05/12/22 Mister Car Wash backs FY22 EPS view of 44c-47c, consensus 46c 05/12/22 Mister Car Wash reports Q1 EPS 11c, consensus 11c 24 Aug MCW Mister Car Wash $12.00 / -0.25 (-2.04%) 08/11/22 Fly Intel: After-Hours Movers 05/13/22 What You Missed On Wall Street On Friday 05/13/22 What You Missed On Wall Street This Morning 03/25/22 What You Missed On Wall Street On Friday

General news	July import prices down 1.4% vs. last month, consensus down 0.9% 08:34 08/12/22 08/12 08:34 08/12/22 08:34 $ECON Economic Data / + ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Hot Stocks	Acer Therapeutics, Relief receive orphan drug designation for ACER-001 » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) , RLFTF Relief / + RELIEF THERAPEUTICS… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/18/22 Acer Therapeutics resubmits NDA for ACER-001 for treatment of UCDs 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA RLFTF Relief / + 07/28/22 Relief, Acer announce submit IND application to FDA for ACER-001 in MSUD 07/28/22 Relief, Acer announce FDA acceptance of review for ACER-001 NDA resubmission 07/08/22 Acer, Relief announces utility model patent issuance for ACER-001 by CNIPA 06/21/22 Acer Therapeutics, Relief announce update on FDA review of NDA for ACER-001 ACER RLFTF ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 01/11/22 H.C. Wainwright Acer Therapeutics assumed with a Buy at H.C. Wainwright 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair RLFTF Relief / + 10/06/21 William Blair Acer Therapeutics set up for 'major event' with NDA accepted, says William Blair ACER ACER Acer Therapeutics $1.48 / -0.03 (-1.99%) 03/02/22 Acer Therapeutics reports Q4 EPS (31c), consensus (1c) 01/15/23 PDUFA Date for ACER-001
Hot Stocks	AGBA Acquisition extends consummation period for business combination » 08:33 08/12/22 08/12 08:33 08/12/22 08:33 AGBA AGBA Acquisition $11.37 / + (+0.00%) AGBA Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	TerrAscend downgraded to Hold from Buy at Craig-Hallum » 08:32 08/12/22 08/12 08:32 08/12/22 08:32 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) Craig-Hallum analyst Eric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 06/02/22 TerrAscend debuts Cookies, Gage brands in New Jersey 03/09/22 TerrAscend to close Gage Growth acquisition on March 10 TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 07:30 Today Cantor Fitzgerald TerrAscend downgraded to Neutral from Overweight at Cantor Fitzgerald 07/22/22 Seaport Global TerrAscend initiated with a Buy at Seaport Global 02/09/22 Clarus TerrAscend price target lowered to C$14 from C$16.25 at Clarus 12/08/21 Cantor Fitzgerald TerrAscend price target raised to $7.65 from $6.70 at Cantor Fitzgerald TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says TRSSF TerrAscend $2.40 / +0.11 (+4.80%) 04/14/22 Here's What You Missed in Cannabis This Week
Recommendations	State Street price target raised to $74 from $67 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 STT State Street $73.51 / +1 (+1.38%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options STT State Street $73.51 / +1 (+1.38%) 07/21/22 State Street appoints Brenda Tsai as global chief marketing officer 07/15/22 State Street raises FY22 NII view to up 24%-27% from up 18%-20% 07/15/22 State Street sees Q3 NII up 5%-9% 07/15/22 State Street says raising prices across services STT State Street $73.51 / +1 (+1.38%) 07/18/22 Deutsche Bank State Street price target raised to $67 from $65 at Deutsche Bank 07/13/22 Deutsche Bank State Street price target lowered to $65 from $67 at Deutsche Bank 07/12/22 Citi State Street price target lowered to $69 from $93 at Citi 07/11/22 UBS State Street price target lowered to $91 from $101 at UBS STT State Street $73.51 / +1 (+1.38%) 07/15/22 State Street reports Q2 ex-items EPS $1.94 vs. $1.57 last year 07/14/22 Notable companies reporting before tomorrow's open 04/14/22 State Street reports Q1 adjusted EPS $1.59, consensus $1.47 04/13/22 Notable companies reporting before tomorrow's open 10 Sep STT State Street $73.51 / +1 (+1.38%) 06/09/22 State Street tells Bloomberg not pursuing any deal with Credit Suisse 06/09/22 State Street says not pursuing any deal with Credit Suisse, Bloomberg reports 06/09/22 Credit Suisse CEO says State Street buyout questions 'really stupid' 06/08/22 State Street tells Bloomberg not responding to Credit Suisse report STT State Street $73.51 / +1 (+1.38%) 07/15/22 What You Missed On Wall Street On Friday 07/15/22 What You Missed On Wall Street This Morning 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/09/22 What You Missed On Wall Street On Thursday STT State Street $73.51 / +1 (+1.38%) 07/15/22 Early notable gainers among liquid option names on July 15th
Recommendations	Invesco price target raised to $20 from $18 at Deutsche Bank » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 IVZ Invesco $18.49 / +0.2925 (+1.61%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly IVZ Invesco $18.49 / +0.2925 (+1.61%) 08/09/22 Invesco reports preliminary AUM $1.45T as of July 31 07/12/22 Invesco reports preliminary AUM $1.39T as of June 30 07/07/22 Invesco Real Estate Income acquires two self-storage portfolios for $42M 06/09/22 Invesco reports AUM of $1.4516B as of May 31, 2022 IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/18/22 JPMorgan Invesco price target lowered to $20 from $22 at JPMorgan 07/13/22 Deutsche Bank Invesco price target lowered to $19 from $21 at Deutsche Bank 07/11/22 UBS Invesco price target lowered to $21 from $27 at UBS 06/28/22 Keefe Bruyette Invesco price target lowered to $18 from $21 at Keefe Bruyette IVZ Invesco $18.49 / +0.2925 (+1.61%) 07/27/22 Invesco reports Q2 adjusted EPS 39c vs. 67c last year 06/20/22 Fly Intel: Top five weekend stock stories 04/26/22 Invesco reports Q1 adjusted EPS 56c, consensus 58c IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/18/22 BlackRock, T. Rowe Price worth a look, Barron's says 05/18/22 GOP looks to curb voting power of BlackRock, other asset managers, WSJ reports IVZ Invesco $18.49 / +0.2925 (+1.61%) 06/13/22 What You Missed On Wall Street On Monday 06/13/22 Fly Intel: Pre-market Movers
Options	One new option listing and one option delisting on August 12th » 08:30 08/12/22 08/12 08:30 08/12/22 08:30 SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) , SYNL Synalloy / + New option listings for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings SLAC SLAC Social Leverage Acquisition Corp I $9.86 / + (+0.00%) 08/01/22 W3BCLOUD to become public through Social Leverage Acquisition Corp I combination SYNL SYNL Synalloy / + 08/09/22 Synalloy reports Q2 EPS $1.06 vs. 31c last year 05/10/22 Synalloy reports Q1 EPS 99c vs. 12c last year
Recommendations	Robinhood price target raised to $10 from $9 at Deutsche Bank » 08:29 08/12/22 08/12 08:29 08/12/22 08:29 HOOD Robinhood $10.51 / -0.08 (-0.76%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood exec sells $1.18M in common stock 08/04/22 Robinhood CEO says in 'great position as a stand-alone company' 08/04/22 SEC probing Robinhood compliance with short selling rules 08/02/22 Robinhood sees FY22 operating expenses $1.7B-$1.76B HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/04/22 Deutsche Bank Robinhood price target raised to $9 from $8 at Deutsche Bank 08/04/22 Mizuho Robinhood price target lowered to $13 from $14 at Mizuho 08/03/22 Piper Sandler Robinhood price target lowered to $10 from $11 at Piper Sandler 07/25/22 JPMorgan JPMorgan sees increased share dilution risk for Coinbase, Robinhood HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/03/22 Notable companies reporting after market close 08/02/22 Robinhood reports Q2 EPS (34c), consensus (37c) 04/28/22 Robinhood reports Q1 EPS (45c), consensus (36c) 04/28/22 Notable companies reporting after market close HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 Judge rules Robinhood must face market manipulation claims, Reuters says 07/20/22 Study finds Robinhood cause of phantom surge in Berkshire Hathaway, WSJ reports 06/27/22 Bankman-Fried says FTX not in active M&A talks with Robinhood, WSJ says 06/27/22 FTX deliberating about potential of deal to buy Robinhood, Bloomberg says HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/11/22 What You Missed On Wall Street On Thursday 08/05/22 Here's What You Missed in Crypto This Week 08/03/22 Fly Intel: After-Hours Movers 08/03/22 What You Missed On Wall Street On Wednesday HOOD Robinhood $10.51 / -0.08 (-0.76%) 08/08/22 Robinhood Markets call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Robinhood Markets call volume above normal and directionally bullish 08/04/22 Unusually active option classes on open August 4th
Recommendations	CorMedix price target lowered to $16 from $27 at Truist » 08:28 08/12/22 08/12 08:28 08/12/22 08:28 CRMD CorMedix $3.72 / +0.345 (+10.22%) Truist analyst Joon Lee… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/11/22 CorMedix expects cash to fund operations at least through 3Q23 08/08/22 CorMedix receives CRL from FDA saying that DefenCath NDA cannot be approved 05/12/22 CorMedix believes it has sufficient resources to fund through 1H of 2023 05/12/22 CorMedix announces leadership updates, operational changes CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/09/22 JMP Securities CorMedix price target lowered to $14 from $19 at JMP Securities 08/09/22 Needham CorMedix price target lowered to $12 from $20 at Needham CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/11/22 CorMedix reports Q2 EPS (19c), consensus (21c) 05/12/22 CorMedix reports Q1 EPS (18c), consensus (22c) 03/29/22 CorMedix reports Q4 EPS (20c), consensus (23c) CRMD CorMedix $3.72 / +0.345 (+10.22%) 08/08/22 Fly Intel: After-Hours Movers 03/29/22 Fly Intel: After-Hours Movers
Recommendations	Franklin Resources price target raised to $29 from $26 at Deutsche Bank » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 BEN Franklin Resources $28.68 / +0.295 (+1.04%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals BEN Franklin Resources $28.68 / +0.295 (+1.04%) 08/09/22 Franklin Resources reports AUM of $1.43T as of July 31, 2022 07/12/22 Franklin Resources reports preliminary AUM $1.379T as of June 30 06/09/22 Franklin Resources reports preliminary AUM $1.45T as of May 31 05/31/22 Franklin Templeton to acquire Alcentra from BNY Mellon in accretive transaction BEN Franklin Resources $28.68 / +0.295 (+1.04%) 07/11/22 UBS Franklin Resources price target lowered to $24 from $27 at UBS 06/28/22 Keefe Bruyette Franklin Resources downgraded to Underperform at Keefe Bruyette 06/28/22 Goldman Sachs Franklin Resources reinstated with a Sell at Goldman Sachs 06/01/22 BMO Capital Franklin Resources price target lowered to $27 from $29 at BMO Capital BEN Franklin Resources $28.68 / +0.295 (+1.04%) 07/28/22 Franklin Resources reports Q3 EPS 82c, consensus 75c 06/20/22 Fly Intel: Top five weekend stock stories 05/03/22 Franklin Resources reports Q2 adjusted EPS 96, consensus 82c BEN Franklin Resources $28.68 / +0.295 (+1.04%) 06/18/22 BlackRock, T. Rowe Price worth a look, Barron's says

Technical Analysis	DJ Transportation Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 $DJT DJ Transportation Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Technical Analysis $DJT DJ Transportation Average / + 06/07/22 Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says $DJT DJ Transportation Average / + 08/11/22 DJ Transportation Average: Pivot points 08/10/22 DJ Transportation Average: Pivot points 08/09/22 DJ Transportation Average: Pivot points 08/08/22 DJ Transportation Average: Pivot points
Technical Analysis	DJ Utility Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 $DJU DJ Utility Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $DJU DJ Utility Average / + 08/11/22 DJ Utility Average: Pivot points 08/10/22 DJ Utility Average: Pivot points 08/09/22 DJ Utility Average: Pivot points 08/08/22 DJ Utility Average: Pivot points
Recommendations	Janus Henderson Group price target raised to $26 from $23 at Deutsche Bank » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 06/21/22 Janus Henderson Group announces Ali Dibadj as CEO 05/14/22 Trian exits Comcast position, increases stake in Invesco 05/04/22 Janus Henderson Group announces new $200M share buyback program 03/23/22 Janus Henderson announces Ali Dibadj as next CEO JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 07/29/22 Citi Janus Henderson Group downgraded to Sell from Neutral at Citi 07/18/22 JPMorgan Janus Henderson Group downgraded to Underweight from Neutral at JPMorgan 07/13/22 Deutsche Bank Janus Henderson Group price target lowered to $23 from $24 at Deutsche Bank 06/28/22 Keefe Bruyette Janus downgraded to Underperform from Market Perform at Keefe Bruyette JHG Janus Henderson Group $25.97 / +0.165 (+0.64%) 07/28/22 Janus Henderson Group reports Q2 adjusted EPS 63c, consensus 65c 05/04/22 Janus Henderson Group reports Q1 adjusted EPS 75c, consensus 86c
Technical Analysis	Dow Jones Industrial Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 DJX Dow Jones Industrial Average / + The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Technical Analysis DJX Dow Jones Industrial Average / + 06/14/22 Ackman says 75 point hike tomorrow can help restore confidence in Fed 05/19/22 Could crypto crash be good for U.S. economy? Probably. DJX Dow Jones Industrial Average / + 02/17/22 JPMorgan JPMorgan now expects seven rate hikes in this year, up from five 01/24/22 JPMorgan JPMorgan macro strategist says market correction in final stages 11/26/21 Morgan Stanley Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley 11/26/21 Credit Suisse Concerns over new Covid variant 'understandable,' says Credit Suisse DJX Dow Jones Industrial Average / + 05/10/22 Tepper says covered Nasdaq short, CNBC reports DJX Dow Jones Industrial Average / + 08/11/22 Dow Jones Industrial Average: Pivot points 08/10/22 Dow Jones Industrial Average: Pivot points 08/09/22 Dow Jones Industrial Average: Pivot points 08/08/22 Dow Jones Industrial Average: Pivot points
Technical Analysis	iShares Transportation Average: Pivot points » 08:27 08/12/22 08/12 08:27 08/12/22 08:27 IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Technical Analysis IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) 06/07/22 Global growth to fall to 2.9% in 2022 from 5.7% in 2021, World Bank says IYT iShares Transportation Average $246.57 / +1.36 (+0.55%) 08/11/22 iShares Transportation Average: Pivot points 08/10/22 iShares Transportation Average: Pivot points 08/09/22 iShares Transportation Average: Pivot points 08/08/22 iShares Transportation Average: Pivot points

Events

Earnings calls, analyst events, roadshows and more

VET
Today at 09:00

Vermilion Energy - VET Conference Calls
SIDU
Today at 09:00

Sidus Space - SIDU Conference Calls
IMH
Today at 09:00

IMPAC Mortgage - IMH Conference Calls
ICCC
Today at 09:00

Immucell - ICCC Conference Calls
BWMN
Today at 09:00

Bowman Consulting - BWMN Conference Calls
SPB
Today at 09:00

Spectrum Brands - SPB Conference Calls
Today at 10:00

Consumer Sentiment Index: August (p) 2022 Government Event
KLXE
Today at 10:00

KLX Energy - KLXE Conference Calls
WLMS
Today at 10:00

Williams Industrial Services - WLMS Conference Calls
STRR
Today at 10:00

Star Equity - STRR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams Priced at: $35.00 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAB X INAB In8bio Secondary Managers: H.C. Wainwright Priced at: $1.90 5.39M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs Priced at: $215.00 1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERT X CERT Certara Spot Secondary Managers: Morgan Stanley $17.75-18.50 7M Shares
Fri	No deals

View All Syndicate Announcements »

Hapag-Lloyd price target raised to EUR 173 from EUR 171 at JPMorgan

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access